Literature DB >> 35246663

ClpP inhibitors are produced by a widespread family of bacterial gene clusters.

Elizabeth J Culp1, David Sychantha1, Christian Hobson1, Andrew C Pawlowski1, Gerd Prehna2, Gerard D Wright3.   

Abstract

The caseinolytic protease (ClpP) is part of a highly conserved proteolytic complex whose disruption can lead to antibacterial activity but for which few specific inhibitors have been discovered. Specialized metabolites produced by bacteria have been shaped by evolution for specific functions, making them a potential source of selective ClpP inhibitors. Here, we describe a target-directed genome mining strategy for discovering ClpP-interacting compounds by searching for biosynthetic gene clusters that contain duplicated copies of ClpP as putative antibiotic resistance genes. We identify a widespread family of ClpP-associated clusters that are known to produce pyrrolizidine alkaloids but whose connection to ClpP has never been made. We show that previously characterized molecules do not affect ClpP function but are shunt metabolites derived from the genuine product of these gene clusters, a reactive covalent ClpP inhibitor. Focusing on one such cryptic gene cluster from Streptomyces cattleya, we identify the relevant inhibitor, which we name clipibicyclene, and show that it potently and selectively inactivates ClpP. Finally, we solve the crystal structure of clipibicyclene-modified Escherichia coli ClpP. Clipibicyclene's discovery reveals the authentic function of a family of natural products whose specificity for ClpP and abundance in nature illuminate the role of eco-evolutionary forces during bacterial competition.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35246663     DOI: 10.1038/s41564-022-01073-4

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   30.964


  42 in total

Review 1.  ClpP: a structurally dynamic protease regulated by AAA+ proteins.

Authors:  John A Alexopoulos; Alba Guarné; Joaquin Ortega
Journal:  J Struct Biol       Date:  2012-05-14       Impact factor: 2.867

Review 2.  AAA+ proteases: ATP-fueled machines of protein destruction.

Authors:  Robert T Sauer; Tania A Baker
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

3.  Discovery of Novel Peptidomimetic Boronate ClpP Inhibitors with Noncanonical Enzyme Mechanism as Potent Virulence Blockers in Vitro and in Vivo.

Authors:  Yuan Ju; Lihui He; Yuanzheng Zhou; Tao Yang; Ke Sun; Rao Song; Yang Yang; Chengwei Li; Zitai Sang; Rui Bao; Youfu Luo
Journal:  J Med Chem       Date:  2020-02-20       Impact factor: 7.446

4.  Acyldepsipeptide antibiotics induce the formation of a structured axial channel in ClpP: A model for the ClpX/ClpA-bound state of ClpP.

Authors:  Dominic Him Shun Li; Yu Seon Chung; Melanie Gloyd; Ebenezer Joseph; Rodolfo Ghirlando; Gerard D Wright; Yi-Qiang Cheng; Michael R Maurizi; Alba Guarné; Joaquin Ortega
Journal:  Chem Biol       Date:  2010-09-24

5.  Structures of ClpP in complex with acyldepsipeptide antibiotics reveal its activation mechanism.

Authors:  Byung-Gil Lee; Eun Young Park; Kyung-Eun Lee; Hyesung Jeon; Kwang Hoon Sung; Holger Paulsen; Helga Rübsamen-Schaeff; Heike Brötz-Oesterhelt; Hyun Kyu Song
Journal:  Nat Struct Mol Biol       Date:  2010-03-21       Impact factor: 15.369

6.  Phenyl Esters Are Potent Inhibitors of Caseinolytic Protease P and Reveal a Stereogenic Switch for Deoligomerization.

Authors:  Mathias W Hackl; Markus Lakemeyer; Maria Dahmen; Manuel Glaser; Axel Pahl; Katrin Lorenz-Baath; Thomas Menzel; Sonja Sievers; Thomas Böttcher; Iris Antes; Herbert Waldmann; Stephan A Sieber
Journal:  J Am Chem Soc       Date:  2015-06-29       Impact factor: 15.419

7.  Antibacterial activity of and resistance to small molecule inhibitors of the ClpP peptidase.

Authors:  Corey L Compton; Karl R Schmitz; Robert T Sauer; Jason K Sello
Journal:  ACS Chem Biol       Date:  2013-10-04       Impact factor: 5.100

8.  Structurally refined beta-lactones as potent inhibitors of devastating bacterial virulence factors.

Authors:  Thomas Böttcher; Stephan A Sieber
Journal:  Chembiochem       Date:  2009-03-02       Impact factor: 3.164

9.  Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues.

Authors:  Paul R Graves; Lucas J Aponte-Collazo; Emily M J Fennell; Adam C Graves; Andrew E Hale; Nedyalka Dicheva; Laura E Herring; Thomas S K Gilbert; Michael P East; Ian M McDonald; Matthew R Lockett; Hani Ashamalla; Nathaniel J Moorman; Donald S Karanewsky; Edwin J Iwanowicz; Ekhson Holmuhamedov; Lee M Graves
Journal:  ACS Chem Biol       Date:  2019-05-01       Impact factor: 4.634

Review 10.  Microbial and fungal protease inhibitors--current and potential applications.

Authors:  Jerica Sabotič; Janko Kos
Journal:  Appl Microbiol Biotechnol       Date:  2012-01-05       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.